Corporate Executive Committee
Gert De Winter
President of the Corporate Executive Committee of the Baloise Group (Group CEO)
Gert De Winter (1966, Belgium, MSc) studied applied economics at the University of Antwerp. From 1988 to 2004 he performed various roles at Accenture in Brussels for issues relating to IT and business transformation management in the financial sector. He was made a partner at the firm in the year 2000. In 2005 he joined the Baloise Group as Chief Information Officer (CIO) and Head of HR of the Mercator insurance company in Belgium. From 2009 to 2015 Gert De Winter was Chief Executive Officer of Baloise Insurance, which was formed in 2011 from the merger of the three insurance companies Mercator, Nateus and Avéro. He has been Group Chief Executive Officer since 1 January 2016. Since June 2016 he has been a member of the Management Board of the Basel Chamber of Commerce.
Head of Finance (CFO)
Carsten Stolz (1968, D/CH, Ph.D.) studied business economics at Fribourg University where he also gained a doctorate specialising in financial management. After that he spent four years as an advisor for the Financial Services practice unit at PricewaterhouseCoopers in Zurich and Geneva, before joining the Baloise Group as Head of Financial Relations. From 2009 to 2011, Dr Carsten Stolz was the Baloise Group’s Head of Financial Accounting & Corporate Finance. Between 2011 and 2017 he was Head of Finance and Risk, and thus a member of the Executive Committee, at Baloise Insurance, Switzerland. Dr Carsten Stolz became a member of the Corporate Executive Committee on 1 May 2017. He manages the Corporate Division Finance with its departments Group Accounting & Controlling, Financial Planning & Analysis, Corporate Communications & Investor Relations, Group Risk Management and Corporate IT as well as the actuary responsible for Swiss business at Baloise and the Head of Regulatory Affairs.
Head of Corporate Division Asset Management
Matthias Henny (1971, CH, Ph. D.) completed his undergraduate and postgraduate studies in physics at the University of Basel. From 1998 to 2003, he was employed at McKinsey & Co., before switching to what was then the Winterthur Group, where he was Head of Financial Engineering in Asset Management until 2007. Subsequently, he was a member of the management team at AXA Winterthur, first as CIO (until 2010), then as CFO. In 2012 Dr Matthias Henny joined the Baloise Group. As CEO of Baloise Asset Management AG he was responsible for the administration of approximately CHF 50 billion in assets. Dr Matthias Henny became a member of the Corporate Executive Committee on 1 May 2017. He manages the Corporate Division Asset Management with its units Investment Strategy and Investment Controlling, Sales and Marketing, Portfolio Management, Operations, Real Estate, Corporate Development and Compliance.
Head of Corporate Center
Thomas Sieber (1965, Switzerland, Dr iur., M.B.L., lawyer, SDM mediator) studied law at the University of St. Gallen. At the beginning of 1994 he qualified to practise as a lawyer in the Swiss canton of Zurich. From 1999 to 2002 he lectured in corporate law at the University of St. Gallen. After brief spells working at Landis & Gyr and Siemens he joined the Baloise Group in 1997 as Deputy Head of Legal & Tax. He became head of this division in 2001 and, in addition, was secretary to Bâloise Holding’s Board of Directors until April 2012. Since 6 December 2007 Dr Thomas Sieber has been a member of the Corporate Executive Committee and, as Head of the Corporate Centre, is responsible for Group Human Resources, Group Strategy and Digital Transformation, Legal and Tax, Group Compliance, Group Procurement and Run-off Business. He also sits on the Board of Directors at Euro Airport Basel-Mulhouse-Freiburg.
CEO Basler Switzerland
Michael Müller (1971, Switzerland, lic. oec. publ.) graduated in economics from the University of Zurich, specialising in insurance and accounting / finance. He began his career with Basler Versicherungen in 1997, starting as a management trainee, then working in Group Finance and eventually becoming Deputy Head and, in 2004, Head of Financial Accounting for the Baloise Group. In 2009, as Head of Finance and Risk, he became a member of the senior management team in Corporate Division Switzerland, focusing on financial reporting and accounting, actuarial management of the insurance companies, risk management and coordination of logistics processes and the pool of project leaders. He has been a member of the Corporate Executive Committee and CEO of Corporate Division Switzerland since March 2011. Michael Müller is a member of the Board of Foundation of Stiftung Finanzplatz Basel, Vice President of the Swiss Insurance Association (SVV) and a member of the Executive Board of the Association of Basel Insurance Companies.
Board of Directors
|Name||Nationality||Born in||Appointed in|
|Dr Andreas Burckhardt, Chairman||CH||1951||1999|
|Dr Andreas Beerli, Vice-Chairman||CH||1951||2011|
|Dr med. Georges-Antoine de Boccard||CH||1951||2011|
|Christoph B. Gloor||CH||1966||2014|
|Dr Thomas von Planta||CH||1961||2017|
|Prof. Dr Hans-Jörg Schmidt-Trenz||D||1959||2018|
|Prof. Dr Marie-Noëlle Venturi - Zen-Ruffinen||CH||1975||2016|
Secretary to the Board of Directors: Dr Philipp Jermann
Andreas Burckhardt (1951, Switzerland, Dr iur., lawyer) has been a member of the Board of Directors since 1999 and its Chairman since 29 April 2011. He studied jurisprudence at the universities of Basel and Geneva. He worked in the legal department of Fides Treuhandgesellschaft from 1982 to 1987 and served as Secretary General of the Baloise Group from 1988 to 1994. He was director and head of the Basel Chamber of Commerce from 1994 to April 2011. In this role he sat on various governing bodies of national and regional business organisations. From 1981 to 2011 he performed various political functions in the Basel civic municipality and in the canton of Basel-Stadt, and from 1997 to 2011 he served on the Great Council of the Canton of Basel-Stadt (as Chairman in 2006 and 2007). Until 2017, he sat on the Board of Directors of Carl Spaeter AG. Dr Andreas Burckhardt is Chairman of the Board of Governors of the Swiss Tropical and Public Health Institute, Basel. He is also a member of the Executive Committee of economiesuisse and sits on the Executive Board of the Employers’ Federation for Basel. Dr Andreas Burckhardt performs a non-executive function as Chairman of Baloise’s Board of Directors.
Andreas Beerli (1951, Switzerland, Dr iur.) has been a member of the Board of Directors since 2011 and Vice-Chairman since 27 April 2018. He studied law at the University of Basel. In 1979 he started working as an underwriter for the German market at Swiss Re. From 1985 to 1993 he performed various managerial roles at Baloise, with the main focus on supervising and supporting several foreign units. He then returned to Swiss Re, where he became a member of the Group Executive Committee in 2000, first in the United States as Head of Swiss Re Americas and, most recently, in Zurich as Chief Operating Officer for the entire Swiss Re Group. Since 2009 he has acted as an independent advisor on the boards of directors and advisory boards of companies and professional associations. He is a member of the Board of Directors at Ironshore Europe Inc., Dublin, a member of the Advisory Board of Accenture Schweiz, and Chairman of the Swiss Advisory Council of the American Swiss Foundation. Dr Andreas Beerli is an independent non-executive director.
Georges-Antoine de Boccard
Georges-Antoine de Boccard (1951, Switzerland, Dr med.) has been a member of the Board of Directors since 2011. He studied medicine at the University of Geneva. He has been running his own urological surgery practice in Geneva since 1987. Dr Georges-Antoine de Boccard chairs the Board at Stellaria Holding SA and at the asset management companies of Citadel Finance SA and GPP-Gestion Patrimoniale Personnalisée SA. He sits on the Board of Directors at the Swiss International Prostate Center SA and Trillium SA. From 2005 to 2006 he was Chairman of the Swiss Association of Urology. He is a member of the Swiss Association of Urology, the European Association of Urology and other professional bodies and associations. Dr Georges-Antoine de Boccard is an independent non-executive director.
Christoph B. Gloor
Christoph B. Gloor (1966, Switzerland, university degree in business
economics) has been a member of the Board of Directors since 2014. He has also been a member of the Executive Committee of Notenstein La Roche Privatbank AG, St. Gallen, since November 2015. He was previously Chief Executive Officer of Basel-based private bank La Roche & Co AG. Prior to joining La Roche & Co AG in 1998, he worked for Swiss Bank Corporation (SBC) before moving to Vitra (International). Christoph B. Gloor served as president of the Association of Swiss Private Banks from November 2013 to February 2015 and was a member of the Board of Directors of the Swiss Bankers Association from September 2013 to February 2015. He has been a member of the Board of Managing Directors of the Basel Banking Association since 2016. Christoph B. Gloor is an independent non-executive director.
Hugo Lasat (1964, Belgium, Master in Economic Sciences, Master in Finance) has been a member of the Board of Directors since 2016. He has been CEO of Brussels-based Degroof Petercam Asset Management (formerly Petercam Institutional Asset Management) since 2011. His managerial roles prior to that include CEO of Amonis Pension Fund and CEO of Candriam Investors Group (previously known as Dexia Asset Management). He is a guest professor at KU Leuven (Brussels Campus) and VIVES University College, member of the Board of Directors of the Belgian Asset Management Association (BEAMA) and a member of the Financial Commission of the Financial Committee of the Belgian Red Cross. Hugo Lasat is an independent non-executive director.
Thomas von Planta
Thomas von Planta (1961, Swiss, Dr iur., lawyer) has been a member of the Board of Directors since 2017. He is the founder and managing director of CorFinAd AG, a company specialising in consultancy for M&A transactions and capital market finance. He has sat on the Board of Directors of Bellevue Group AG since 2007 as well as Bank am Bellevue AG and Bellevue Asset Management AG since 2012, and has been Chairman of the Board of Directors of all three companies since March 2015. Before that, he had worked for Goldman Sachs in Zurich, Frankfurt and London for around ten years and had been the interim Head of Investment Banking and Head of Corporate Finance for the Vontobel Group in Zurich between 2002 and 2006. Dr Thomas von Planta is an independent non-executive director.
Thomas Pleines (1955, Germany, lawyer) has been a member of the Board of Directors since 2012. From 2003 to 2005 he was CEO and delegate of the Board of Directors at Allianz Suisse, Zurich, and from 2006 to 2010 he was CEO of Allianz Versicherungs-AG, Munich, and an executive director at Allianz Deutschland AG, Munich. Since 2011 he has chaired the presidential boards of DEKRA e.V., Stuttgart, and DEKRA e.V. Dresden as well as the supervisory boards of DEKRA SE, Stuttgart, and SÜDVERS Holding GmbH & Co. KG, Au near Freiburg. Thomas Pleines is an independent non-executive director.
Hans-Jörg Schmidt-Trenz (1959, Germany, Prof. Dr rer. pol.) has been a member of the Board of Directors since 2018. He is Professor of Economics at Saarland University (since 2000) and the University of Hamburg (since 2008) as well as President of the HSBA Hamburg School of Business Administration (since 2004). From 1996 to 2017, he was the Chief Executive Officer of the Hamburg Chamber of Commerce. He is Chairman of the European Chief Executive Officers working group (since 2000), a member of the board of trustees of HASPA Hamburger Sparkasse (since 1997) and on the board of trustees of the Alexander Otto Sports Foundation (since 2007), in the General Council and Executive Committee of the International Chamber of Commerce (since 2014), on the Advisory Board of the HIP Hamburg Innovation Port (since 2017) and a representative and counsellor of the Hamburg Chamber of Commerce (since 2017). Professor Hans-Jörg Schmidt-Trenz is an independent non-executive director.
Marie-Noëlle Venturi - Zen-Ruffinen
Marie-Noëlle Venturi - Zen-Ruffinen (1975, Switzerland, Prof. Dr iur., lawyer) has been a member of the Board of Directors since 2016. She holds a PhD and master’s degree in law and a master’s degree in philosophy from the University of Fribourg. She is a lawyer and honorary professor at the School of Economics and Management at the University of Geneva, where she mainly lectures on corporate law. Professor Marie-Noëlle Venturi - Zen-Ruffinen was a partner in the Geneva law firm Tavernier Tschanz until 2012, and since that time has been of counsel for the firm. She is president of the Swiss Board Institute foundation and sits on the Board of Management of the Swiss Institute of Directors. Professor Marie-Noëlle Venturi - Zen-Ruffinen is an independent non-executive director.
The Board of Directors has four committees, which support it in its activities. These committees report to the Board of Directors and submit the necessary proposals for their particular areas of responsibility. The Investment Committee and the Remuneration Committee have their own decision-making powers.
The committees appointed by the Board of Directors generally consist of four members, who are newly elected every year by the Board of Directors. In accordance with section 7 VegüV, the members of the Remuneration Committee are to be elected by the Annual General Meeting from 2014. The Chairman and Vice-Chairman of the Board of Directors are ex officio members of the Chairman’s Committee. The Chairman of the Board of Directors is not allowed to sit on the Audit and Risk Committee. The committees’ basic functions and responsibilities are specified in the Organisational Regulations and in the written regulations applicable to individual committees, which also govern administrative aspects.
The Chairman’s Committee provides advice on key transactions, especially those involving important strategic or personnelrelated decisions. Consequently, it also does the necessary preparatory work on HR issues.
The Investment Committee’s main responsibilities are to oversee the Baloise Group’s investment activities, define the basic principles of its investment policy, specify the asset allocation strategy for all strategic business units and devise the relevant investment plan.
Until now the Remuneration Committee has specified the structure and amount of remuneration paid to the members of the Board of Directors and of the salaries paid to the members of the Corporate Executive Committee. Under the VegüV, the remuneration of the Board of Directors and Corporate Executive Committee has to be approved by the Annual General Meeting from 2014. The Remuneration Committee will therefore submit the necessary proposals to the Board of Directors for presentation to the Annual General Meeting. The Remuneration Committee approves the target agreements and performance assessments that are applied to the Corporate Executive Committee members in order to determine their variable remuneration. It also sanctions the remuneration policies applicable to the Corporate Executive Committee members and ensures that they are being correctly implemented. It approves the variable remuneration granted to individual members of the Corporate Executive Committee; from 2014 this remuneration has to be within the maximum amount approved by the Annual General Meeting. Furthermore, it specifies the total amount available in the performance pool.
Audit and Risk Committee
The Audit and Risk Committee supports the Board of Directors in its non-delegable overarching supervisory and financial oversight functions (section 716a OR) by ascertaining whether the internal and external control systems, including risk management, are well organised and function properly, by assessing the situation with respect to compliance in the Company and by forming its own view of the Company’s separate and consolidated annual financial statements. It receives regular reports on the work and findings of Group Internal Audit and on cooperation with the external auditors.
Structure of the committees
Dr Andreas Burckhardt, Chairman
Dr Andreas Beerli, Vice-Chairman
Thomas Pleines, Member
Dr Thomas von Planta, Member
Investment Committee Dr Andreas Burckhardt, Chair
Christoph B. Gloor, Deputy Chair
Hugo Lasat, Member
Dr med. Georges-Antoine de Boccard, Member
Audit and Risk Committee
Dr Andreas Beerli, Chair
Christoph B. Gloor, Deputy Chair
Dr Thomas von Planta, Member
Prof. Dr Marie-Noëlle Venturi - Zen-Ruffinen, Member
Remuneration Committee Thomas Pleines, Chair
Karin Keller-Sutter, Deputy Chair
Dr med. Georges-Antoine de Boccard, Member
Prof. Dr Hans-Jörg Schmidt-Trenz, Member